-
NMPA Announcement on Issuing the Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-Quality Industry Development
2025-12-22
The release of the Opinions is an important measure by the NMPA to implement the strategic deployment of the Party Central Committee and the State Council on comprehensive deepening of reform and promoting high-quality development. It will better safeguard the people's demand for cosmetics and inject a strong impetus into the high-quality development of the cosmetics industry.
-
Li Li meets with head of BPOM of Indonesia
2025-11-13
On Nov 11, Li Li, commissioner of the National Medical Products Administration (NMPA), met in Beijing with a delegation led by Taruna Ikrar, head of the Food and Drug Supervisory Authority (BPOM) of Indonesia.
-
Yang Sheng meets with WHO officials
2025-11-12
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), met with Rogerio Gaspar, Director of the Regulation and Prequalification Department of the World Health Organization (WHO) and WHO Representative to China, Martin Taylor, in Beijing on Nov 7.
-
Yang Sheng leads delegation to 8th CIIE in Shanghai
2025-11-11
From Nov 4 to 6, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), led a delegation to attend the 8th China International Import Expo (CIIE) in Shanghai.
-
NMPA holds training session on QMS internal audit
2025-11-11
To further advance the regulatory Quality Management System (QMS) and promote its sustainable and standardized operation, the National Medical Products Administration (NMPA) held a specific training session in Beijing on Oct 31 for QMS internal auditors engaged in vaccine regulation and pharmaceutical production inspection.
-
Revision and Release of the Good Manufacturing Practice for Medical Devices
2025-11-07
On November 4, the National Medical Products Administration (NMPA) released the revised version of the Good Manufacturing Practice for Medical Devices (hereinafter referred to as the GMP). The new GMP for medical devices shall come into effect as of November 1, 2026.
